The American Journal of Medicine
Volume 120, Issue 2 , Pages 172-179 , February 2007

Frequent Needle Exchange Use and HIV Incidence in Vancouver, Canada

  • Evan Wood, PhD

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, BC, Canada
    • Department of Medicine, University of British Columbia, Vancouver
    • Corresponding Author InformationRequests for reprints should be addressed to Evan Wood, PhD, BC Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada.
    • ,
  • Elisa Lloyd-Smith

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, BC, Canada
    • Department of Health Care and Epidemiology, University of British Columbia, Vancouver
    • ,
  • Kathy Li

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, BC, Canada
    • ,
  • Steffanie A. Strathdee

      Affiliations

    • Department of Family and Preventive Medicine, University of California, San Diego.
    • ,
  • Will Small

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, BC, Canada
    • ,
  • Mark W. Tyndall

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, BC, Canada
    • Department of Medicine, University of British Columbia, Vancouver
    • ,
  • Julio S.G. Montaner

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, BC, Canada
    • Department of Medicine, University of British Columbia, Vancouver
    • ,
  • Thomas Kerr

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, BC, Canada
    • Department of Medicine, University of British Columbia, Vancouver

References 

  1. Hamers FF, Downs AM. HIV in central and eastern Europe. Lancet. 2003;361:1035–1044
  2. Kitayaporn D, Uneklabh C, Weniger BG, et al. HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS. 1994;8:1443–1450
  3. Des Jarlais DC, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995;274:1226–1231
  4. Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS. 2000;14:605–611
  5. Wood E, Tyndall MW, Spittal PM, et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS. 2002;16:941–943
  6. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987–991
  7. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997;349:1797–1800
  8. Heimer R, Kaplan EH, Khoshnood K, Jariwala B, Cadman EC. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. Am J Med. 1993;95:214–220
  9. Vlahov D, Des Jarlais DC, Goosby E, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol. 2001;154(12 Suppl):S70–S77
  10. Normand J, Vlahov D, Moses LE. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC: National Academy Press; 1995;
  11. Lurie P, Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet. 1997;349:604–608
  12. Kerr T, Kaplan K, Suwannawong P, Jurgens R, Wood E. The Global Fund to Fight AIDS, Tuberculosis and Malaria: funding for unpopular public-health programmes. Lancet. 2004;364:11–12
  13. Wolfe D, Malinowska-Sempruch K. A working paper commissioned by the HIV/AIDS Task Force of the Millennium Project Illicit drug policies and the global HIV epidemic: effects of UN and national government approaches. New York, NY: Open Society Institute; 2004;Available at: http://www.soros.org/initiatives/health/focus/ihrd/articles_publications/publications/cnd_20040316. Accessed January 23, 2006.
  14. Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:F59–F65
  15. Task Force Report on a Site Visit to Vancouver. Washington, DC: Office of National Drug Control Policy, Executive Office of the President; 1998;
  16. Bellm J. Needle-exchange programmes are not the answer. Lancet. 1999;353:1657–1661
  17. Moss AR. For God’s sake, don’t show this letter to the president …. [comment] Am J Public Health. 2000;90:1395–1396
  18. Coutinho RA. Needle exchange, pragmatism, and moralism. Am J Public Health. 2000;90:1387–1388
  19. Souder, Mark E. Souder to NIH: Harm Reduction Causes Harm [letter]. April 27, 2004. Available at: http://www.drugpolicy.org/library/05_06_04souder.cfm. Accessed January 23, 2006.
  20. Bennett SS. Harm reduction and needle exchange programmes. Lancet. 1998;351:1819
  21. Deadly ignorance. In: Washington Post. 2005;p. B6;February 27
  22. Phillips MM. Bush ties money for AIDS work to a policy pledge. In: Wall Street Journal. 2005;p. A3;February 28
  23. Ideology and AIDS. [editorial] New York Times. 2005;February 26
  24. Schechter MT, Strathdee SA, Cornelisse PG, et al. Do needle exchange programmes increase the spread of HIV among injection drug users? (An investigation of the Vancouver outbreak). AIDS. 1999;13:F45–F51
  25. Tyndall MW, Currie S, Spittal P, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17:887–893
  26. Miller CL, Spittal PM, LaLiberte N, et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr. 2002;30:335–341
  27. Wood E, Tyndall MW, Spittal P, et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemic. Int J Drug Policy. 2002;13:95–102
  28. Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 1989;261:561–565
  29. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989;321:874–879
  30. Corneil TA, Kuyper LM, Shoveller J, et al. Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place. 2006;12:79–85
  31. Kuyper LM, Palepu A, Kerr T, et al. Factors associated with sex-trade involvement among female injection drug users in a Canadian setting. Addict Res Theory. 2005;13:193–199
  32. Wood E, Spittal P, Li K, et al. Inability to access addiction treatment and risk of HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2004;36:750–754
  33. Spittal PM, Small W, Wood E, et al. How otherwise dedicated AIDS prevention workers come to support state-sponsored shortage of clean syringes in Vancouver, Canada. Int J Drug Policy. 2004;15:36–45
  34. Wood E, Tyndall MW, Spittal PM, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?. CMAJ. 2001;165:405–410
  35. Elliott R, Csete J, Palepu A, Kerr T. Reason and rights in global drug control policy. CMAJ. 2005;172:655–656
  36. “Thematic topic: HIV/AIDS in the context of drug use.” Paper for Intersessional Working Group on Thematic Drug (2nd meeting, 20 October 2004) regarding UN Commission on Narcotic Drugs, 48th Session.
  37. Hagan H, McGough JP, Thiede H, Hopkins SG, Weiss NS, Alexander ER. Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs. J Urban Health. 2000;77:103–112
  38. Safaeian M, Brookmeyer R, Vlahov D, Latkin C, Marx M, Strathdee SA. Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. Am J Epidemiol. 2002;155:169–175
  39. Lurie P. Invited commentary: le mystère de Montréal. Am J Epidemiol. 1997;146:1003–1006discussion 1007-1010

PII: S0002-9343(06)00279-8

doi: 10.1016/j.amjmed.2006.02.030

The American Journal of Medicine
Volume 120, Issue 2 , Pages 172-179 , February 2007

Article Tools

* Image Usage & Resolution